OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
OncClub: Join the Chat on Trending Trials in CancerComplimentary print subscription for home or office deliveryIn-person and virtual events just for HCPsLively expert panel discussions featuring peer-to-peer exchangesSubscribe to our eNewsletter for breaking news and curated content
Specialty
View MoreBreast CancerCAR T-cell TherapyChronic Lymphocytic LeukemiaGastrointestinal CancerGenitourinary CancersGynecologic OncologyImmuno-OncologyLung CancerMelanoma & Skin CancerMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • OncClub: Join the Chat on Trending Trials in Cancer
  • Complimentary print subscription for home or office delivery
  • In-person and virtual events just for HCPs
  • Lively expert panel discussions featuring peer-to-peer exchanges
  • Subscribe to our eNewsletter for breaking news and curated content
SpecialtySee All >
  • Breast Cancer
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Global Outlook on Advanced Nonsquamous NSCLC

EP. 1: Upfront Immunotherapy for NSCLC

October 17th 2017

EP. 2: Reliability of PD-L1 Testing in NSCLC

October 17th 2017

EP. 3: NSCLC: Approach for Progression on Chemotherapy

October 17th 2017

EP. 4: Duration of Immunotherapy for NSCLC

October 17th 2017

EP. 5: NSCLC: Immunotherapy Beyond Progression

October 17th 2017

EP. 6: Osimertinib as Frontline Therapy for EGFR-Positive NSCLC

October 17th 2017

EP. 7: Managing CNS Metastases in EGFR-Positive NSCLC

October 17th 2017

EP. 8: EGFR-Positive NSCLC: Treatment at Progression

October 17th 2017

EP. 9: Upfront Therapy for ALK/ROS1-Rearranged NSCLC

October 17th 2017

EP. 10: ALEX Trial: Frontline Therapy for ALK-Rearranged NSCLC

October 17th 2017

EP. 11: Second-Line Brigatinib for ALK-Rearranged NSCLC

October 17th 2017

EP. 12: Changing Treatment Paradigm for BRAF-Mutant NSCLC

October 17th 2017

EP. 13: NSCLC: Promising Molecular Targets

October 17th 2017

EP. 14: Consolidation Immunotherapy for Locally Advanced NSCLC

October 17th 2017

EP. 15: Emerging Therapies for Nonsquamous NSCLC

October 17th 2017